Approaches for the Cure of Type 1 Diabetes by Cellular and Gene Therapy

Authors: Jun, H.- S.; Yoon, J.- W.

Source: Current Gene Therapy, Volume 5, Number 2, April 2005 , pp. 249-262(14)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

OR

Price: $63.10 plus tax (Refund Policy)

Abstract:

Type 1 diabetes results from insulin deficiency caused by autoimmune destruction of insulin-producing pancreatic bgr cells. Islet transplantation, bgr cell regeneration, and insulin gene therapy have been explored in an attempt to cure type 1 diabetes. Major progress on islet transplantation includes substantial improvements in islet isolation technology to obtain viable and functionally intact islets and less toxic immunosuppressive drug regimes to prevent islet graft failure. However, the availability of human islets from cadaveric pancreata is limited. Regeneration of pancreatic bgr cells from embryonic or adult stem cells may overcome the limited source of islets and transplant rejection if bgr cells are regenerated from endogenous stem cells. However, it is difficult to overcome the persisting hostile bgr cell-specific autoimmune response that may destroy the regenerated bgr cells. Insulin gene therapy might overcome the weakness of islet transplantation and bgr cell regeneration with respect to their vulnerability to autoimmune attack. This method replaces the function of bgr cells by introducing various components of the insulin synthetic and secretory machinery into non- bgr cells, which are not targets of bgr cell-specific autoimmune responses. However, there is no regulatory system that results in the expression and release of insulin in response to glucose with satisfactory kinetics. Although there is no perfect solution for the cure of type 1 diabetes at the present time, research on a variety of potential approaches will offer the best choices for the cure of human type 1 diabetes.

Keywords: type 1 diabetes; islet transplantation; regeneration; embryonic stem cells; adult stem cells; specific autoimmunity; insulin gene therapy

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1566523053544209

Affiliations: 1: Rosalind Franklin Comprehensive Diabetes Center, The Chicago Medical School, 3333 Green Bay Road, North Chicago, IL, 60064, USA.

Publication date: 2005-04-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page